New partnership announced between BioAgilytix and CTI

Written by Karen Al-Litani

Leading global CRO BioAgilytix (NC, USA) has signed a formal, worldwide partnership agreement with global full-service CRO Clinical Trial and Consulting Services (CTI, OH, USA). This partnership will enable BioAgilytix and CTI to streamline the experience of their customers in providing mutually complementary services and in turn expedite the drug development process. BioAgilytix’s strategy for this alliance with CTI is to amplify its range of services and competencies for clients involved in the full lifecycle development spectrum. You may also be interested in: Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit for vector-based cell and gene therapies Insightful Science acquires...

To view this content, please register now for access

It's completely free